FFA
IBB icon

Farther Finance Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Farther Finance Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.25M Sell
10,666
-2,481
-19% -$498K 0.02% 713
2026
Q2 		$2.5M Sell
13,147
-351
-3% -$60.3K 0.02% 641
2026
Q1 		$2.3M Buy
13,498
+4,424
+49% +$756K 0.02% 586
2025
Q4 		$1.53M Buy
9,074
+3,681
+68% +$598K 0.02% 698
2025
Q3 		$779K Buy
5,393
+88
+2% +$12K 0.01% 854
2025
Q2 		$671K Sell
5,305
-852
-14% -$105K 0.01% 765
2025
Q1 		$766K Sell
6,157
-276
-4% -$37.4K 0.02% 614
2024
Q4 		$850K Buy
6,433
+663
+11% +$93.2K 0.03% 414
2024
Q3 		$840K Buy
5,770
+2,264
+65% +$328K 0.03% 402
2024
Q2 		$480K Buy
3,506
+163
+5% +$21.8K 0.02% 492
2024
Q1 		$457K Buy
3,343
+2,236
+202% +$305K 0.03% 420
2023
Q4 		$150K Buy
1,107
+70
+7% +$8.54K 0.01% 650
2023
Q3 		$127K Buy
1,037
+554
+115% +$70.5K 0.02% 489
2023
Q2 		$61.3K Sell
483
-1,085
-69% -$141K 0.01% 600
2023
Q1 		$203K Buy
1,568
+1,300
+485% +$170K 0.06% 260
2022
Q4 		$35.2K Buy
+268
New +$34.6K 0.01% 576

Other funds holding IBB

AC
Apella Capital West Hartford, Connecticut $7.88B AUM 10.78% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
NRS
Neville Rodie & Shaw New York $1.48B AUM 34.49% 1-Year Est. Return
MCM
Monument Capital Management Alexandria, Virginia $480M AUM 43.68% 1-Year Est. Return
AIM
Acropolis Investment Management St. Louis, Missouri $2.49B AUM 10.8% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
KIG
Kessler Investment Group Columbus, Indiana $207M AUM 43.85% 1-Year Est. Return
DI
Decision Investments San Diego, California $110M AUM 52.83% 1-Year Est. Return
GLLW
Graves Light Lenhart Wealth Harrisonburg, Virginia $1.07B AUM 10.8% 1-Year Est. Return

Farther Finance Advisors's IBB Position: Q3 2026 in Review

Farther Finance Advisors reduced its iShares Biotechnology ETF (IBB) stake by 19% in Q3 2026, selling an estimated $498K and leaving 10,666 shares worth $2.25M. The position accounts for 0.02% of the portfolio, ranked #713.

Farther Finance Advisors first reported a position in IBB in Q4 2022 and has held it in 16 quarters since. The position peaked at $2.5M in Q2 2026. 35 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Farther Finance Advisors held 10,666 shares of iShares Biotechnology ETF worth $2.25M as of Q3 2026.
  • Farther Finance Advisors sold 2,481 iShares Biotechnology ETF shares in Q3 2026, an estimated $498K.
  • iShares Biotechnology ETF made up 0.02% of Farther Finance Advisors's portfolio in Q3 2026, its #713 holding.
  • Farther Finance Advisors first reported a position in iShares Biotechnology ETF in Q4 2022 and has held it in 16 quarters since.
  • Farther Finance Advisors's iShares Biotechnology ETF position peaked at $2.5M in Q2 2026.
  • 35 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.